Whitefort Capital Management’s Trinity Biotech TRIB Stock Holding History

Whitefort Capital Management’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,730	Closed	-$53.2K	–	20
2025 Q2	$53.2K	Hold	2,730	–	–	0.02%	18
2025 Q1	$46.7K	Hold	2,730	–	–	0.02%	15
2024 Q4	$72.1K	Hold	2,730	–	–	0.03%	17
2024 Q3	$90.1K	Hold	2,730	–	–	0.04%	17
2024 Q2	$174K	Hold	2,730	–	–	0.11%	21
2024 Q1	$167K	Hold	2,730	–	–	0.1%	17
2023 Q4	$176K	Hold	2,730	–	–	0.11%	19
2023 Q3	$301K	Hold	2,730	–	–	0.16%	17
2023 Q2	$389K	Hold	2,730	–	–	0.37%	12
2023 Q1	$385K	Hold	2,730	–	–	0.36%	13
2022 Q4	$405K	Hold	2,730	–	–	0.32%	15
2022 Q3	$439K	Hold	2,730	–	–	0.49%	12
2022 Q2	$502K	Hold	2,730	–	–	0.63%	11
2022 Q1	$434K	Buy	2,730 +2,496	+1,067%	+$431K	0.41%	21
2021 Q4	$50K	Buy	+234	New	+$66.3K	0.04%	38

Other funds holding TRIB

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

MAWA

Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

BCM

Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return

Whitefort Capital Management's TRIB Position: Q3 2025 in Review

Whitefort Capital Management sold out of Trinity Biotech (TRIB) in Q3 2025, closing a stake of 2,730 shares — an estimated $53.2K sold.

Whitefort Capital Management first reported a position in TRIB in Q4 2021 and held it in 15 quarters. The position peaked at $502K in Q2 2022. 26 funds tracked by Wall St. Rank hold TRIB as of Q3 2025.

Whitefort Capital Management reported no remaining Trinity Biotech position as of Q3 2025 after selling out during the quarter.
Whitefort Capital Management sold 2,730 Trinity Biotech shares in Q3 2025, an estimated $53.2K.
Whitefort Capital Management first reported a position in Trinity Biotech in Q4 2021 and held it in 15 quarters.
Whitefort Capital Management's Trinity Biotech position peaked at $502K in Q2 2022.
26 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2025.

Based on Whitefort Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.